Hsiao-Ching Huang

Aug 7, 2024 | ajmc.com | Hsiao-Ching Huang |Daniel R. Touchette |Mina Tadrous |Glen T. Schumock |Saria S. Awadalla |Todd Lee

ABSTRACTObjectives: Adherence to medications is important for the management of chronic diseases. Although the proportion of days covered (PDC) is a common metric for measuring adherence, it may be insufficient to distinguish relevant differences in medication-taking behavior. Group-based trajectory models (GBTMs) have been used to better represent adherence over time.

Jan 8, 2024 | jnccn.org | Hsiao-Ching Huang |Gregory S. Calip |Jennifer Weiss |Yael Simons

Background The Oncotype 21-gene breast recurrence score (RS) is the most commonly ordered multigene breast cancer biomarker in the United States,1 and the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer base its recommendations on the RS for patients with estrogen receptor (ER)–positive, HER2-negative tumors (henceforth referred to as ER-positive) that do not have axillary lymph node metastases.2 The 21-gene RS was developed as a predictive biomarker because...